Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.8701
-0.0009 (-0.10%)
At close: May 12, 2025, 4:00 PM
0.8701
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
Cytosorbents Revenue
In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth. Cytosorbents had revenue of $6.52M in the quarter ending December 31, 2024, with 91.65% growth.
Revenue (ttm)
$35.59M
Revenue Growth
+14.51%
P/S Ratio
1.33
Revenue / Employee
$238,889
Employees
149
Market Cap
55.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.59M | 4.51M | 14.51% |
| Dec 31, 2023 | 31.08M | -3.60M | -10.39% |
| Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
| Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
| Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
CTSO News
- 11 days ago - CytoSorbents Provides Regulatory Update for DrugSorb-ATR - PRNewsWire
- 13 days ago - CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 21 days ago - CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program - PRNewsWire
- 25 days ago - CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - PRNewsWire
- 4 weeks ago - CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America - PRNewsWire
- 5 weeks ago - CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - PRNewsWire
- 6 weeks ago - Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - PRNewsWire